[Effects of doxapram on chronic respiratory insufficiency].
D000136:Acid-Base Equilibrium; D000368:Aged; D001784:Blood Gas Analysis; D001794:Blood Pressure; D000697:Central Nervous System Stimulants / Q000627:therapeutic use*; D002908:Chronic Disease; D004315:Doxapram / Q000008:administration & dosage / Q000627:therapeutic use; D005260:Female; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007275:Injections, Intravenous; D008297:Male; D008875:Middle Aged; D009025:Morpholines / Q000627:therapeutic use*; D010101:Oxygen Consumption; D011760:Pyrrolidinones / Q000627:therapeutic use*; D012131:Respiratory Insufficiency / Q000188:drug therapy*; D014655:Vascular Resistance
D000697:Central Nervous System Stimulants; D009025:Morpholines; D011760:Pyrrolidinones; D004315:Doxapram
Effets du doxapram dans l'insuffisance respiratoire chronique.